Wells Fargo’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
49,289
+2,875
| +6% | +$10.4K | ﹤0.01% | 4450 |
|
|
2025
Q1 | $139K | Buy |
46,414
+1,023
| +2% | +$3.06K | ﹤0.01% | 4472 |
|
|
2024
Q4 | $152K | Buy |
45,391
+9,865
| +28% | +$33K | ﹤0.01% | 4471 |
|
|
2024
Q3 | $119K | Buy |
35,526
+1,172
| +3% | +$3.93K | ﹤0.01% | 4521 |
|
|
2024
Q2 | $114K | Buy |
34,354
+6,815
| +25% | +$22.6K | ﹤0.01% | 4498 |
|
|
2024
Q1 | $111K | Buy |
27,539
+3,475
| +14% | +$14K | ﹤0.01% | 4458 |
|
|
2023
Q4 | $73.4K | Buy |
24,064
+4,612
| +24% | +$14.1K | ﹤0.01% | 4684 |
|
|
2023
Q3 | $58.4K | Sell |
19,452
-10,249
| -35% | -$30.7K | ﹤0.01% | 4760 |
|
|
2023
Q2 | $111K | Buy |
29,701
+15,637
| +111% | +$58.5K | ﹤0.01% | 4708 |
|
|
2023
Q1 | $47.1K | Buy |
14,064
+13,564
| +2,713% | +$45.4K | ﹤0.01% | 4896 |
|
|
2022
Q4 | $2.41K | Sell |
500
-195
| -28% | -$938 | ﹤0.01% | 5640 |
|
|
2022
Q3 | $4K | Sell |
695
-622
| -47% | -$3.58K | ﹤0.01% | 5626 |
|
|
2022
Q2 | $10K | Sell |
1,317
-29,016
| -96% | -$220K | ﹤0.01% | 5445 |
|
|
2022
Q1 | $219K | Sell |
30,333
-21,430
| -41% | -$155K | ﹤0.01% | 4631 |
|
|
2021
Q4 | $463K | Sell |
51,763
-229,956
| -82% | -$2.06M | ﹤0.01% | 4408 |
|
|
2021
Q3 | $9.88M | Buy |
281,719
+281,441
| +101,238% | +$9.87M | ﹤0.01% | 2153 |
|
|
2021
Q2 | $6K | Sell |
278
-4,288
| -94% | -$92.5K | ﹤0.01% | 5934 |
|
|
2021
Q1 | $282K | Sell |
4,566
-2,996
| -40% | -$185K | ﹤0.01% | 4686 |
|
|
2020
Q4 | $316K | Buy |
+7,562
| New | +$316K | ﹤0.01% | 4739 |
|